At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Descemet Endothelial Thickness Comparison Trial
In Brief
A Phase 4 clinical trial evaluating DSAEK, DMEK, and 6 other interventions for Keratoplasty and 4 related conditions. Targeting 38 participants across 3 sites.
Detailed Summary
The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
Study Details
Timeline
Interventions
The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument.
Prednisolone is a corticosteroid used to alleviate swelling post-surgery.
Ofloxacin is an antibiotic used to treat bacterial infections of the eye.
Tropicamide is a prescription drug used to dilate pupils during an eye exam.
Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.